Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Feldman, Steven

One or more keywords matched the following items that are connected to Feldman, Steven

Item Type	Name
Academic Article	The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life?
Academic Article	Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments.
Academic Article	Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period.
Academic Article	Drug Safety.
Academic Article	Psoriasis and its treatment with adalimumab.
Academic Article	Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk.
Academic Article	Tattoo sites and psoriasis.
Academic Article	Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
Academic Article	Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
Academic Article	Infliximab for inpatient psoriasis management--is there a role?
Academic Article	New treatments for psoriasis: which biologic is best?
Academic Article	A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
Academic Article	Misunderstandings.
Academic Article	Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Academic Article	Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Academic Article	Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
Academic Article	Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis.
Academic Article	Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States.
Academic Article	Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
Academic Article	Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
Academic Article	Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis.
Academic Article	Infections associated with the use of tumor necrosis factor-a inhibitors in psoriasis.
Concept	Antibodies, Monoclonal
Concept	Antibodies
Academic Article	Cost effectiveness of biologic therapies for plaque psoriasis.
Academic Article	Department of Dermatology was blessed with a wonderful psoriasis specialist. Foreword.
Academic Article	Adherence to adalimumab in patients with moderate to severe psoriasis.
Academic Article	Adherence to ustekinumab in psoriasis patients.
Academic Article	Trends in systemic psoriasis treatment therapies from 1993 through 2010.
Academic Article	The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials.
Academic Article	Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate.
Academic Article	Dupilumab for the treatment of atopic dermatitis: A clinical trial review.
Academic Article	Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice.
Academic Article	Interleukin-31 pathway and its role in atopic dermatitis: a systematic review.
Academic Article	Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis.
Academic Article	Dupilumab for atopic dermatitis.
Academic Article	Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
Academic Article	Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials.
Academic Article	Adherence to biologics in patients with psoriasis.
Academic Article	Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.
Academic Article	Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study.
Academic Article	Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States.
Academic Article	The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans.
Academic Article	Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.
Academic Article	Risankizumab for psoriasis.
Academic Article	Relative efficacy of systemic treatments for atopic dermatitis.
Academic Article	Tildrakizumab: A Review of Phase II and III Clinical Trials.
Academic Article	Secukinumab for psoriasis in a patient with hepatitis B.
Academic Article	Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.
Academic Article	Tildrakizumab: interpreting the data.

Search Criteria

Antibodies